MDAI Stock Overview
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Spectral AI, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.86 |
| 52 Week High | US$19.50 |
| 52 Week Low | US$1.70 |
| Beta | 0.55 |
| 1 Month Change | -12.68% |
| 3 Month Change | -36.08% |
| 1 Year Change | -81.98% |
| 3 Year Change | -81.00% |
| 5 Year Change | n/a |
| Change since IPO | -80.82% |
Recent News & Updates
Shareholder Returns
| MDAI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.8% | 2.0% | 2.2% |
| 1Y | -82.0% | -1.4% | 22.8% |
Return vs Industry: MDAI underperformed the US Medical Equipment industry which returned -2% over the past year.
Return vs Market: MDAI underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| MDAI volatility | |
|---|---|
| MDAI Average Weekly Movement | 16.7% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDAI's share price has been volatile over the past 3 months.
Volatility Over Time: MDAI's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 78 | Pete Carlson | www.spectral-ai.com |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals.
Spectral AI, Inc. Fundamentals Summary
| MDAI fundamental statistics | |
|---|---|
| Market cap | US$32.34m |
| Earnings (TTM) | -US$20.85m |
| Revenue (TTM) | US$18.06m |
1.8x
P/S Ratio-1.6x
P/E RatioIs MDAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDAI income statement (TTM) | |
|---|---|
| Revenue | US$18.06m |
| Cost of Revenue | US$10.18m |
| Gross Profit | US$7.88m |
| Other Expenses | US$28.73m |
| Earnings | -US$20.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -1.19 |
| Gross Margin | 43.64% |
| Net Profit Margin | -115.50% |
| Debt/Equity Ratio | -25.5% |
How did MDAI perform over the long term?
See historical performance and comparison